Funda Meric‐Bernstam

1. Recommendations for the use of next-generation sequencing (NGS) for patients with metastatic cancers: a report from the ESMO Precision Medicine Working Group
   2020/08/24 by F. Mosele, Fernanda Mosele, J. Remon +39 · 4 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Genetic factors in colorectal cancer #Pancreatic and Hepatic Oncology Research
2. Recommendations for the use of next-generation sequencing (NGS) for patients with advanced cancer in 2024: a report from the ESMO Precision Medicine Working Group
   2024/05/27 by M.F. Mosele, C.B. Westphalen, C. Benedikt Westphalen +38 · 9 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer Genomics and Diagnostics #Lung Cancer Treatments and Mutations #Colorectal Cancer Treatments and Studies
3. Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial
   2023/10/23 by Funda Meric‐Bernstam, Funda Meric-Bernstam, Vicky Makker +22 · 4 citations
   Medicine · #Advanced Breast Cancer Therapies #Cancer Treatment and Pharmacology #HER2/EGFR in Cancer Research
4. TRPS1: a highly sensitive and specific marker for breast carcinoma, especially for triple-negative breast cancer
   2020/10/03 by Di Ai, Jun Yao, Fei Yang +29 · 2 citations
   Medicine · #Breast Lesions and Carcinomas #Cancer and Skin Lesions #Metastasis and carcinoma case studies